Rankings
▼
Calendar
ZTS Q1 2020 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$52B
Q1 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.5B
+5.4% YoY
Gross Profit
$1.0B
67.5% margin
Operating Income
$539M
35.1% margin
Net Income
$423M
27.6% margin
EPS (Diluted)
$0.88
QoQ Revenue Growth
-8.4%
Cash Flow
Operating Cash Flow
$408M
Free Cash Flow
$314M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$11.5B
Total Liabilities
$8.8B
Stockholders' Equity
$2.8B
Cash & Equivalents
$1.9B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.5B
$1.5B
+5.4%
Gross Profit
$1.0B
$899M
+15.1%
Operating Income
$539M
$428M
+25.9%
Net Income
$423M
$312M
+35.6%
Revenue Segments
Dogs and Cats
$746M
50%
Cattle
$370M
25%
Swine
$157M
10%
Poultry
$148M
10%
Horses
$51M
3%
Fish
$26M
2%
Geographic Segments
United States Segment
$786M
52%
International Segment
$728M
48%
← FY 2020
All Quarters
Q2 2020 →